Peer-Reviewed Study Establishes Consistent Quality and Early Clinical Success of Ossium’s Proprietary Off-the-Shelf Bone Marrow

A peer-reviewed study published in Cytotherapy highlights the early clinical success of Ossium Health's cryopreserved bone marrow as an off-the-shelf graft for allogeneic hematopoietic cell transplantation. The study demonstrates that Ossium's GMP-manufactured bone marrow can be produced consistently and delivered quickly, overcoming the logistical challenges of fresh grafts. Clinical results from three high-risk AML patients showed rapid engraftment and no adverse events, reinforcing the biological potency of Ossium's approach. This research challenges the assumption that fresh grafts are superior, paving the way for more predictable access to life-saving therapies.